Balance Sheet
Accounts PayablesCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dr Reddys Laboratories (RDY) Inventory: 2018-2025

  • Dr Reddys Laboratories' Inventory rose 9.04% to $832.0 million in Q1 2025 from the same period last year, while for Mar 2025 it was $832.0 million, marking a year-over-year increase of 9.04%. This contributed to the annual value of $832.0 million for FY2025, which is 9.04% up from last year.
  • Dr Reddys Laboratories' Inventory amounted to $832.0 million in Q1 2025, which was up 9.04% from $763.0 million recorded in Q1 2024.
  • Over the past 5 years, Dr Reddys Laboratories' Inventory peaked at $832.0 million during Q1 2025, and registered a low of $592.0 million during Q1 2023.
  • Its 3-year average for Inventory is $729.0 million, with a median of $763.0 million in 2024.
  • Per our database at Business Quant, Dr Reddys Laboratories' Inventory surged by 33.55% in 2021 and then fell by 11.77% in 2023.
  • Dr Reddys Laboratories' Inventory (Quarterly) stood at $621.0 million in 2021, then rose by 8.05% to $671.0 million in 2022, then fell by 11.77% to $592.0 million in 2023, then climbed by 28.89% to $763.0 million in 2024, then increased by 9.04% to $832.0 million in 2025.
  • Its Inventory stands at $832.0 million for Q1 2025, versus $763.0 million for Q1 2024 and $592.0 million for Q1 2023.